AU8891291A - Use of interferon and a substrate with an antimalarial activity for the treatment of malaria infections - Google Patents

Use of interferon and a substrate with an antimalarial activity for the treatment of malaria infections

Info

Publication number
AU8891291A
AU8891291A AU88912/91A AU8891291A AU8891291A AU 8891291 A AU8891291 A AU 8891291A AU 88912/91 A AU88912/91 A AU 88912/91A AU 8891291 A AU8891291 A AU 8891291A AU 8891291 A AU8891291 A AU 8891291A
Authority
AU
Australia
Prior art keywords
interferon
substrate
treatment
antimalarial activity
malaria infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU88912/91A
Inventor
Ulrich Bienzle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU8891291A publication Critical patent/AU8891291A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU88912/91A 1990-12-07 1991-12-06 Use of interferon and a substrate with an antimalarial activity for the treatment of malaria infections Abandoned AU8891291A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4039114 1990-12-07
DE4039114A DE4039114A1 (en) 1990-12-07 1990-12-07 MEDICINAL PRODUCTS AND THEIR USE FOR TREATING MALARIA INFECTIONS

Publications (1)

Publication Number Publication Date
AU8891291A true AU8891291A (en) 1992-06-11

Family

ID=6419830

Family Applications (1)

Application Number Title Priority Date Filing Date
AU88912/91A Abandoned AU8891291A (en) 1990-12-07 1991-12-06 Use of interferon and a substrate with an antimalarial activity for the treatment of malaria infections

Country Status (9)

Country Link
EP (1) EP0490250A3 (en)
JP (1) JPH04316522A (en)
KR (1) KR920011518A (en)
AU (1) AU8891291A (en)
CA (1) CA2057157A1 (en)
DE (1) DE4039114A1 (en)
IE (1) IE914250A1 (en)
IL (1) IL100243A0 (en)
ZA (1) ZA919647B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004174A1 (en) * 1992-08-21 1994-03-03 The University Of Melbourne Cytokine applications

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2349644A (en) 1999-05-01 2000-11-08 Biointeractions Ltd Infection resistant polymers, methods for their preparation, and their uses
GB0103668D0 (en) 2001-02-15 2001-03-28 Biointeractions Ltd Methods and clinical devices for the inhibition or prevention of mammalian cell growth
US9707284B2 (en) 2006-06-01 2017-07-18 The Regents Of The University Of California Formulations of peptides and chloroquines for the treatment of pathogenic immune responses in immune mediated diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4915941A (en) * 1986-12-11 1990-04-10 New York University Method for preventing the development or decreasing the extent of malarial parasitemia

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004174A1 (en) * 1992-08-21 1994-03-03 The University Of Melbourne Cytokine applications

Also Published As

Publication number Publication date
EP0490250A3 (en) 1992-12-02
CA2057157A1 (en) 1992-06-08
IE914250A1 (en) 1992-06-17
KR920011518A (en) 1992-07-24
ZA919647B (en) 1992-07-29
IL100243A0 (en) 1992-09-06
JPH04316522A (en) 1992-11-06
DE4039114A1 (en) 1992-06-11
EP0490250A2 (en) 1992-06-17

Similar Documents

Publication Publication Date Title
AU5433494A (en) Injector and use of the same
AU8328691A (en) Isocarbostiryl compounds and antitumor use thereof
DE69317890T2 (en) ATTACHABLE AND RE-ATTACHABLE ADHESIVE ITEM
AU8028591A (en) Absorbent products having integral transverse retaining tab and pocket
AU3087989A (en) Amorphous oxide film and article having such film thereon
AU4629593A (en) Suction catheter assemblies
AU9010791A (en) Oxides and the production thereof
AU4623693A (en) Suction catheter assemblies
AU4098393A (en) Laminate and use of the same
AU7824191A (en) Medicament-containing article and device therefor
AU9113991A (en) Mutant orientable proteins and coated substrates
AU3176393A (en) Antimalarial bisquinolines
AU3328693A (en) Treatment of fungal infections
AU7114991A (en) Aminoguanidine assay and applications thereof
AU661337B2 (en) 2-(9h-xanthem-9-yl)acetamide and analogues
AU650928B2 (en) Coated article
AU8152691A (en) Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same
AU642751B2 (en) New embodiments of the HIV principal neutralizing determinant
AU8891291A (en) Use of interferon and a substrate with an antimalarial activity for the treatment of malaria infections
AU3366193A (en) Fine gauge needles and cannulae
AU2409992A (en) Carcinostatic compound and production thereof
AU2246692A (en) Fastener coating and process
AU666405B2 (en) Suction catheter assemblies
AU6112890A (en) Application aid and the use thereof
AU1764292A (en) Re-catalyst and carrier